What is it about?
This article provides new observations about the role SFTL1 plays in the osteoarthritis
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
SFTL1 low dose can promote chondrogenic differentiation, while high levels can actively contribute to enhancing joint inflammation
Perspectives
We suggest that SFTL1 can be considered in the promoting of chondrogenic differentiation in a concentration manner in the treatment of osteoarthritis
Dr Murad Alahdal
Johns Hopkins University
Read the Original
This page is a summary of: Molecular functions of FSTL1 in the osteoarthritis, International Immunopharmacology, June 2020, Elsevier,
DOI: 10.1016/j.intimp.2020.106465.
You can read the full text:
Contributors
The following have contributed to this page
